AI-based Measurements of Tumour Burden in PSMA PET-CT

Recruiting now

Conditions studied: Prostate Cancer

In brief

The primary aim of the present study is to evaluate how automatically calculated (by an AI-based method) tumour burden, measured as tumour volume (TV) and as tumour uptake (TU: TV x SUVmean) in the prostate/prostate bed, pelvic lymph nodes, distant lymph nodes, bone and as the total tumour burden predicts overall survival (OS) in patients with prostate cancer (newly diagnosed and patients with biochemical recurrence).

Key facts

Study ID

NCT06363435

Run by

Elin Tragardh

People needed

1500

Starts

2024-03-29

Expected to finish

2033-03-01

Last updated by the study team

2026-04-28

Who can join

Age: 20 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients referred to a clinically indicated 18F-PSMA-1007 PET-CT scan at Skåne University Hospital, Lund or Malmö, Sweden

You may not qualify if…

• Patients under 20 years old

Where it is running

• Skåne University Hospital — Lund, Sweden (enrolling)
• Skåne university hospital — Malmö, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.